PPH Legal Blog

Due to the fall-out from Avandia and other diabetes drugs, the FDA is considering stricter rules for testing the effects of diabetes drugs on the human heart prior to sale.
Drug safety advocates are praising the move while investors aren’t too keen on the idea. All of the concerns follow reports that Avandia increases an individual’s […]

[Read more →]

A 2007 law that requires all clinical studies of new medications, except Phase-1 Safety Studies, is increasing the amount of information available to patients and doctors alike.
This new law is particularly useful because pharmaceutical companies frequently don’t disclose any negative results of their clinical trials. In addition, they don’t publish results that show very little […]

[Read more →]

The FDA’s recently criticized review and approval process is under investigation by the Government Accountability Office. The GAO is investigating reports that the review process allowed 2 blockbuster drugs through without sufficient proof of their effectiveness or lack of harmful side effects.
Sen. Charles Grassley, an Iowa Republican, requested the investigation after studies have shown that […]

[Read more →]

A lawsuit has been filed in U.S. District Court in Pennsylvania against the makers of Avandia. It claims that the makers should have known of the possible risks of taking Avandia which include a significant increased risk of heart failure, heart attack and stroke.
According to the plaintiff’s lawyers, taking Avandia caused him to have significant heart […]

[Read more →]

The family of nurse Milagros Larosa, 65, has filed a wrongful death lawsuit against the maker of Avandia, GlaxoSmithKline.
In the course of a year, Ms. Larosa was hospitalized 3 times for heart problems. Prior to taking Avandia, she had not had any heart problems or heart conditions. Ms. Larosa died of a stroke in December […]

[Read more →]